Scientists test 'Living Drug' to reboot immune system in tough lupus cases
NCT ID NCT06189157
First seen Nov 01, 2025 · Last updated Apr 22, 2026 · Updated 22 times
Summary
This early-stage trial is testing a new cell therapy called MB-CART19.1 for adults with severe lupus that hasn't responded to standard treatments. Doctors will modify a patient's own immune cells (T cells) to target and reduce the harmful B cells thought to drive lupus. The main goals are to find a safe dose and see if this one-time treatment can put the disease into remission.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLE - SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Otto-von-Guericke-Universität Magdeburg
RECRUITINGMagdeburg, Germany
Contact
Contact
-
Universitatsklinikum Tubingen - Medizinische Universitätsklinik Abt. II
RECRUITINGTübingen, Germany
Contact
Contact
-
Universitätsklinikum Erlangen, Medizinische Klinik 3
NOT_YET_RECRUITINGErlangen, Germany
Contact
Contact
Conditions
Explore the condition pages connected to this study.